Maxwell Biosciences, Inc. — Form D
Maxwell Biosciences, Inc. of Austin, TX, a company, filed a Form D exempt-offering notice with the SEC on 2022-04-05. The offering totals $14.8M, of which $10.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-04-05
- Form: D
- Accession: 0001907465-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.8M
- Amount sold: $10.9M
- Remaining: $4.0M
- Investors: 96
- Date of first sale: 2021-10-04
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-440517
Issuer
- Name: Maxwell Biosciences, Inc.
- CIK: 0001907465
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3809 Juniper Trace, Austin, TX, 78738
- Phone: 855-629-2461
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Christopher Johns | Director | Austin, TX |
| Theodore Moskovitz | Director | Austin, TX |
| Praveen Tyle | Director | Encinitas, CA |
| Annelise Barron | Director | Irvine, CA |
| Joshua McClure | Director | Austin, TX |
| Joshua McClure | Executive Officer | Austin, TX |
| Joshua McClure | Promoter | Austin, TX |
| Kate McKinley | Director | Austin, TX |
| Barbara R Holcomb | Director | Austin, TX |
Other filings by this issuer (1)
More